Jefferies Reiterates Buy Rating on AC Immune SA (ACIU): '2025 financials largely immaterial'

March 13, 2026 9:05 AM

Jefferies analyst Lucy Codrington reiterated a Buy rating and $7.00 price target on AC Immune SA (NASDAQ: ACIU)The analyst commented ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found